619 related articles for article (PubMed ID: 21671892)
1. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
2. [Non adherence and topical steroids].
Aubert H; Barbarot S
Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S7-12. PubMed ID: 22305285
[TBL] [Abstract][Full Text] [Related]
3. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway.
Gustavsen HE; Gjersvik P
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):168. PubMed ID: 25174954
[No Abstract] [Full Text] [Related]
4. [Corticosteroid phobia in patients with atopic dermatitis].
Jenerowicz D; Czarnecka-Operacz M; Silny W
Wiad Lek; 2005; 58(11-12):607-15. PubMed ID: 16594469
[TBL] [Abstract][Full Text] [Related]
5. Topical Corticosteroid Phobia in Atopic Dermatitis: A Systematic Review.
Li AW; Yin ES; Antaya RJ
JAMA Dermatol; 2017 Oct; 153(10):1036-1042. PubMed ID: 28724128
[TBL] [Abstract][Full Text] [Related]
6. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.
El Hachem M; Gesualdo F; Ricci G; Diociaiuti A; Giraldi L; Ametrano O; Occella C; Fortina AB; Milioto M; Arcangeli F; Simonetti O; Giancristoforo S; Calamelli E; Mazzatenta C; Neri I
Ital J Pediatr; 2017 Feb; 43(1):22. PubMed ID: 28245844
[TBL] [Abstract][Full Text] [Related]
7. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
Gollnick H; Luger T; Freytag S; Bräutigam M;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
[TBL] [Abstract][Full Text] [Related]
8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
9. The frequency and intensity of topical pimecrolimus treatment in children with physician-confirmed mild to moderate atopic dermatitis.
Kapoor R; Hoffstad O; Bilker W; Margolis DJ
Pediatr Dermatol; 2009; 26(6):682-7. PubMed ID: 20199441
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
Kirsner RS; Heffernan MP; Antaya R
Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
13. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
14. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of glucocorticoid receptor beta in lymphocytes of patients with severe atopic dermatitis unresponsive to topical corticosteroid.
Hägg PM; Hurskainen T; Palatsi R; Ilves M; Oikarinen A
Br J Dermatol; 2010 Feb; 162(2):318-24. PubMed ID: 19903176
[TBL] [Abstract][Full Text] [Related]
16. Topical corticosteroid phobia in patients with atopic eczema.
Charman CR; Morris AD; Williams HC
Br J Dermatol; 2000 May; 142(5):931-6. PubMed ID: 10809850
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid Phobia Among Pharmacists Regarding Atopic Dermatitis in Children: A National French Survey.
Raffin D; Giraudeau B; Samimi M; Machet L; Pourrat X; Maruani A
Acta Derm Venereol; 2016 Feb; 96(2):177-80. PubMed ID: 26039683
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with steroid phobia in caregivers of children with atopic dermatitis.
Kojima R; Fujiwara T; Matsuda A; Narita M; Matsubara O; Nonoyama S; Ohya Y; Saito H; Matsumoto K
Pediatr Dermatol; 2013; 30(1):29-35. PubMed ID: 22747965
[TBL] [Abstract][Full Text] [Related]
19. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.
Koster ES; Philbert D; Wagelaar KR; Galle S; Bouvy ML
Int J Clin Pharm; 2019 Jun; 41(3):711-718. PubMed ID: 31020600
[TBL] [Abstract][Full Text] [Related]
20. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.
Yentzer BA; Camacho FT; Young T; Fountain JM; Clark AR; Feldman SR
J Drugs Dermatol; 2010 Apr; 9(4):324-9. PubMed ID: 20514788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
